1 READ MORE: GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds NAION moves the discussion beyond the retina A 2024 matched cohort study reporting increased NAION incidence among semaglutide-prescribed patients drew wide attention across ophthalmology, prompting debate over whether the association reflects a true optic nerve safety signal or the underlying vascular risk profiles of diabetic and obese populations
The change is part of the Defense Health Agencys implementation of regulatory controls on weight loss medication coverage, according to an Aug
What is the best diet to follow while taking tirzepatide for weight loss
Weight loss is not exclusively fat loss
What GLP1s are and how they work GLP-1s, also known as GLP-1 receptor agonists, are medications designed to mimic action of glucagon-like peptide-1 (GLP-1), a hormone the body naturally releases after eating
From there, we build a treatment plan that works alongside your Mounjaro